|
US1998A
(en)
|
|
1841-03-12 |
|
Refrigerator |
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
DE3853515T3
(de)
|
1987-05-21 |
2005-08-25 |
Micromet Ag |
Multifunktionelle proteine mit vorbestimmter zielsetzung.
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
JPH05504476A
(ja)
|
1989-12-27 |
1993-07-15 |
アメリカ合衆国 |
ヒト胃癌検出用診断プローブ
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
|
US5589579A
(en)
|
1994-07-19 |
1996-12-31 |
Cytoclonal Pharmaceutics, Inc. |
Gene sequence and probe for a marker of non-small cell lung carinoma
|
|
WO2000075316A1
(en)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5677139A
(en)
|
1995-04-21 |
1997-10-14 |
President And Fellows Of Harvard College |
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
KR19990077146A
(ko)
|
1996-01-11 |
1999-10-25 |
길리스 스티브 |
유방암의 치료 및 진단용 조성물 및 방법
|
|
WO2001049715A2
(en)
|
2000-01-06 |
2001-07-12 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
WO2000075327A1
(en)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
|
US20070224663A1
(en)
|
1997-03-07 |
2007-09-27 |
Human Genome Sciences, Inc. |
Human Secreted Proteins
|
|
US7368531B2
(en)
*
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
WO2000056889A2
(en)
|
1999-03-23 |
2000-09-28 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030073129A1
(en)
|
1998-09-01 |
2003-04-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030022298A1
(en)
|
1997-09-15 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020127584A1
(en)
|
1997-09-18 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030027272A1
(en)
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030166107A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030008352A1
(en)
|
1997-09-18 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20050196832A1
(en)
|
1997-09-18 |
2005-09-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030166104A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7160985B2
(en)
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US20030022835A1
(en)
|
1998-04-29 |
2003-01-30 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
|
US20030040471A1
(en)
|
1998-04-29 |
2003-02-27 |
Watson James D. |
Compositions isolated from skin cells and methods for their use
|
|
JP3428441B2
(ja)
|
1998-05-15 |
2003-07-22 |
エーザイ株式会社 |
タイトジャンクション構成膜蛋白質クローディンファミリー
|
|
US7319008B2
(en)
|
1998-06-02 |
2008-01-15 |
Genentech, Inc. |
Nucleic acid underexpressed in melanoma
|
|
US7351543B2
(en)
|
1998-06-02 |
2008-04-01 |
Genentech, Inc. |
Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
|
|
JP2002517222A
(ja)
*
|
1998-06-11 |
2002-06-18 |
スミスクライン ビーチャム コーポレーション |
Ｇｐｒ３５ａ受容体
|
|
US7339033B2
(en)
|
1998-06-26 |
2008-03-04 |
Genentech, Inc. |
Pro1481
|
|
EP1104486A4
(en)
|
1998-08-04 |
2002-07-17 |
Diadexus Llc |
NEW METHOD FOR DIAGNOSIS, FOLLOW-UP, AND IMAGE OF LUNG CANCER
|
|
US7538086B2
(en)
|
1998-09-01 |
2009-05-26 |
Genentech, Inc. |
PRO1303 polypeptides
|
|
NZ510464A
(en)
|
1998-09-01 |
2004-05-28 |
Genentech Inc |
Further pro polypeptides and sequences thereof
|
|
US20030082626A1
(en)
|
1998-09-01 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7488796B2
(en)
|
1998-09-01 |
2009-02-10 |
Genentech, Inc. |
PRO1269 polypeptides
|
|
US20050181478A1
(en)
|
1998-09-01 |
2005-08-18 |
Baker Kevin P. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
MXPA01002592A
(es)
|
1998-09-16 |
2004-06-07 |
Genentech Inc |
Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos.
|
|
JP2002524103A
(ja)
|
1998-09-16 |
2002-08-06 |
ザイモジェネティクス，インコーポレイティド |
胃ポリペプチドｚｓｉｇ２８
|
|
EP1119620A2
(en)
|
1998-10-06 |
2001-08-01 |
Curagen Corporation |
Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses
|
|
US7399834B2
(en)
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
|
EP1080209A2
(en)
*
|
1998-10-21 |
2001-03-07 |
Arch Development Corporation |
Methods of treatment of type 2 diabetes
|
|
US7026449B2
(en)
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU768694B2
(en)
|
1999-03-08 |
2004-01-08 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
|
AU2883600A
(en)
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7507404B2
(en)
|
1999-03-08 |
2009-03-24 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7109292B2
(en)
|
1999-03-08 |
2006-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
JP2004507202A
(ja)
|
1999-03-31 |
2004-03-11 |
キュラジェン コーポレイション |
ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」
|
|
US20080286821A1
(en)
|
1999-05-14 |
2008-11-20 |
Eaton Dan L |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
JP2004522402A
(ja)
|
1999-06-02 |
2004-07-29 |
ジェネンテック・インコーポレーテッド |
同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
|
|
CA2373915A1
(en)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
CA2372511C
(en)
|
1999-06-15 |
2011-11-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU2883700A
(en)
|
1999-06-23 |
2001-01-09 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU2883900A
(en)
|
1999-07-07 |
2001-01-30 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1208202A2
(en)
*
|
1999-09-01 |
2002-05-29 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU1205901A
(en)
|
1999-10-14 |
2001-04-23 |
Board Of Trustees Of The University Of Arkansas, The |
Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof
|
|
EP1686134A3
(en)
|
1999-12-01 |
2006-08-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
|
CA2396719A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
22 human secreted proteins
|
|
US20040018969A1
(en)
|
2000-01-31 |
2004-01-29 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
WO2001055343A1
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2001055326A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
CA2401070A1
(en)
|
2000-02-22 |
2001-08-30 |
Corixa Corporation |
Compositions and methods for diagnosis and therapy of malignant mesothelioma
|
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU4592601A
(en)
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
CA2405550A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2001090357A1
(en)
|
2000-05-24 |
2001-11-29 |
Genesis Research & Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
|
AU2001271589A1
(en)
|
2000-06-30 |
2002-01-14 |
Zymogenetics Inc. |
Mammalian secreted proteins
|
|
CA2634294A1
(en)
|
2000-08-03 |
2002-02-14 |
Therapeutic Human Polyclonals, Inc. |
Production of humanized antibodies in transgenic animals
|
|
MXPA03001468A
(es)
|
2000-08-15 |
2004-05-04 |
Immunex Corp |
Polipeptidos de claudia.
|
|
EP1309679A2
(en)
|
2000-08-16 |
2003-05-14 |
Chiron Corporation |
Human genes and gene expression products
|
|
AU2001229509A1
(en)
*
|
2000-08-18 |
2002-03-04 |
Human Genome Sciences, Inc. |
11 human secreted proteins
|
|
US20030017468A1
(en)
|
2000-08-28 |
2003-01-23 |
Sei-Yu Chen |
Compositions and methods relating to lung specific genes
|
|
EP2298789B1
(en)
|
2000-09-08 |
2012-03-14 |
Schering Corporation |
Mammalian genes; related reagents and methods
|
|
JP2004526411A
(ja)
|
2000-09-18 |
2004-09-02 |
トマス・ジエフアーソン・ユニバーシテイ |
胃および食道癌細胞を同定および標的とするための組成物および方法
|
|
DK1354034T3
(da)
|
2000-11-30 |
2008-03-25 |
Medarex Inc |
Transgene transchromosomale gnavere til fremstilling af humane antistoffer
|
|
WO2002061087A2
(en)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
|
|
WO2002068579A2
(en)
|
2001-01-10 |
2002-09-06 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
EP1368499A2
(en)
|
2001-01-29 |
2003-12-10 |
Phase-1 Molecular Toxicology Inc. |
Rat toxicologically relevant genes and uses thereof
|
|
CN1516706A
(zh)
*
|
2001-02-26 |
2004-07-28 |
阿伦纳药品公司 |
人g蛋白偶联受体的内源性和非内源性形式
|
|
US20030152939A1
(en)
|
2001-04-09 |
2003-08-14 |
Glennda Smithson |
Novel secreted proteins and polynucleotides encoding them
|
|
US20060084794A1
(en)
|
2001-04-12 |
2006-04-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP2003000249A
(ja)
|
2001-05-10 |
2003-01-07 |
Daiichi Fine Chemical Co Ltd |
クローディンによるＭＴ−ＭＭＰｓを介したｐｒｏＭＭＰ−２活性化
|
|
CA2449042A1
(en)
*
|
2001-05-30 |
2002-12-27 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
EP1493028A4
(en)
|
2001-07-06 |
2006-06-14 |
Genentech Inc |
PHAGEN DISPLAY PRESENTED LIGANDS OF THE PDZ DOMAIN
|
|
AU2002321903A1
(en)
|
2001-08-03 |
2003-02-24 |
Arbor Vita Corporation |
Molecular interactions in cells
|
|
WO2004045535A2
(en)
|
2002-11-14 |
2004-06-03 |
Arbor Vita Corporation |
Molecular interactions in neurons
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US7202335B2
(en)
|
2001-12-06 |
2007-04-10 |
Genentech, Inc. |
PRO300 polypeptides
|
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
|
WO2003072824A1
(fr)
*
|
2002-02-28 |
2003-09-04 |
Sankyo Company,Limited |
Marqueurs de prevision d'etats pathologiques lies a l'insuffisance cardiaque et procede d'utilisation
|
|
CA2379661A1
(en)
|
2002-03-28 |
2003-09-28 |
Kursad Turksen |
Paracellular drug delivery system
|
|
AU2003240495A1
(en)
|
2002-06-04 |
2003-12-19 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
|
CA2499816C
(en)
|
2002-09-27 |
2013-07-30 |
Xencor, Inc. |
Optimized fc variants and methods for their generation
|
|
WO2004035607A2
(en)
|
2002-10-17 |
2004-04-29 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
EP1430902A1
(en)
|
2002-12-20 |
2004-06-23 |
Mondobiotech Laboratories Anstalt |
Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale
|
|
EP1587540B1
(en)
|
2003-01-09 |
2021-09-15 |
MacroGenics, Inc. |
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
KR20060031809A
(ko)
|
2003-06-09 |
2006-04-13 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암 치료 및 진단용 조성물 및 방법
|
|
JP2007507243A
(ja)
|
2003-10-03 |
2007-03-29 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
遺伝子発現プロファイルおよび使用方法
|
|
DE10354601B3
(de)
|
2003-11-21 |
2005-06-23 |
Chiropro Gmbh |
Gelenkprothese für Fingerglieder
|
|
WO2005052182A2
(en)
|
2003-11-26 |
2005-06-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
A method of analyzing plasma membrane protein content of cells
|
|
US7858322B2
(en)
|
2003-12-23 |
2010-12-28 |
Nono, Inc. |
Method of determining inhibition of binding to TRPM7 protein
|
|
WO2005076939A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Kentucky Research Foundation |
Assay and method for diagnosing and treating alzheimer’s disease
|
|
EP1732582A2
(en)
|
2004-02-26 |
2006-12-20 |
Ohio University |
Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
|
|
US20050255041A1
(en)
|
2004-05-13 |
2005-11-17 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2005114221A2
(en)
|
2004-05-21 |
2005-12-01 |
The Institute For Systems Biology |
Compositions and methods for quantification of serum glycoproteins
|
|
WO2006023121A1
(en)
|
2004-07-27 |
2006-03-02 |
Ohio University |
Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in white adipose tissue (13)
|
|
DE102004042822A1
(de)
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
|
FR2876705B1
(fr)
|
2004-10-19 |
2008-12-12 |
Biomerieux Sa |
Procede pour le diagnostic d'une intolerance a l'aspirine
|
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
|
WO2007018843A2
(en)
|
2005-07-01 |
2007-02-15 |
Arbor Vita Corporation |
Methods and compositions for diagnosis and treatment of influenza
|
|
ZA200800970B
(en)
|
2005-08-15 |
2009-10-28 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
|
WO2007027867A2
(en)
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
JP2009508493A
(ja)
|
2005-09-19 |
2009-03-05 |
ベリデックス・エルエルシー |
すい臓がんを診断するための方法
|
|
CA2625403A1
(en)
|
2005-10-17 |
2007-04-26 |
Institute For System Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
KR20080106946A
(ko)
|
2006-03-29 |
2008-12-09 |
제넨테크, 인크. |
종양의 진단 및 치료
|
|
WO2008013954A2
(en)
|
2006-07-27 |
2008-01-31 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
JP5244103B2
(ja)
|
2006-08-09 |
2013-07-24 |
ホームステッド クリニカル コーポレイション |
器官特異的蛋白質およびその使用方法
|
|
WO2008021115A2
(en)
|
2006-08-14 |
2008-02-21 |
The Brigham And Women's Hospital, Inc. |
Diagnostic tests using gene expression ratios
|
|
RU2009114745A
(ru)
|
2006-09-19 |
2010-10-27 |
Новартис АГ (CH) |
Биомаркеры, предназначенные для выявления направленной модуляции, эффективности ингибиторов raf, применения с целью диагностики и/или прогнозирования
|
|
WO2008043561A2
(en)
|
2006-10-11 |
2008-04-17 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Influenza targets
|
|
EP2097538A4
(en)
|
2006-12-07 |
2011-11-30 |
Switchgear Genomics |
TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
|
|
AU2007333106A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-20 regulated genes and pathways as targets for therapeutic intervention
|
|
BRPI0807227A2
(pt)
|
2007-02-01 |
2019-01-22 |
Veridex Llc |
métodos e materiais para identificação da origem de um carcinoma de origem primária desconhecida
|
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP1997832A1
(en)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
|
WO2008154333A2
(en)
|
2007-06-08 |
2008-12-18 |
Asuragen, Inc. |
Mir-34 regulated genes and pathways as targets for therapeutic intervention
|
|
WO2008152822A1
(ja)
|
2007-06-15 |
2008-12-18 |
Medinet Co., Ltd. |
医薬
|
|
US20100292303A1
(en)
|
2007-07-20 |
2010-11-18 |
Birrer Michael J |
Gene expression profile for predicting ovarian cancer patient survival
|
|
WO2009035497A2
(en)
|
2007-08-08 |
2009-03-19 |
Savidge Tor C |
Disease related cysteine modifications and uses thereof
|
|
EP2036987A1
(en)
|
2007-09-17 |
2009-03-18 |
Siemens Healthcare Diagnostics GmbH |
Molecular markers for tumor cell content in tissue samples
|
|
WO2009038090A1
(ja)
|
2007-09-19 |
2009-03-26 |
Suntory Holdings Limited |
セサミン類とアラキドン酸類を含有する組成物
|
|
CA2702180A1
(en)
|
2007-10-12 |
2009-04-16 |
Peter Humphries |
Method for opening tight junctions
|
|
WO2009102367A2
(en)
|
2007-11-19 |
2009-08-20 |
The Regents Of The University Of Colorado |
Tight junction protein modulators and uses thereof
|
|
WO2009148593A1
(en)
|
2008-06-02 |
2009-12-10 |
Nsabp Foundation, Inc. |
Identification and use of prognostic and predictive markers in cancer treatment
|
|
WO2010046889A1
(en)
|
2008-10-23 |
2010-04-29 |
Quark Pharmaceuticals, Inc. |
Methods for delivery of sirna to bone marrow cells and uses thereof
|
|
CN101381524A
(zh)
|
2008-10-24 |
2009-03-11 |
南开大学 |
单层氧化石墨与水溶性高分子增强复合材料
|
|
GB0904957D0
(en)
|
2009-03-23 |
2009-05-06 |
Univ Erasmus Medical Ct |
Tumour gene profile
|
|
WO2010120526A2
(en)
|
2009-03-31 |
2010-10-21 |
Emory University |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
|
CN101584860A
(zh)
|
2009-04-27 |
2009-11-25 |
西安杰诺瓦生物科技有限公司 |
重组人Claudin18.2肿瘤疫苗及其制备方法
|
|
WO2010141093A2
(en)
|
2009-06-04 |
2010-12-09 |
The University Of Maryland, Baltimore |
Co-signaling methods for treating cancers
|
|
AU2010302955A1
(en)
|
2009-10-01 |
2012-05-17 |
Chipdx Llc |
System and method for classification of patients
|
|
CA2782620A1
(en)
|
2009-12-01 |
2011-06-09 |
Compendia Bioscience, Inc. |
Classification of cancers
|
|
CA2786940C
(en)
|
2010-03-16 |
2019-09-24 |
Biontech Ag |
Tumor vaccination involving a humoral immune response, and proteins therefor including all or a portion of a hepatitis b virus core antigen protein and an epitope of claudin 18.2
|
|
EP2366709A1
(en)
|
2010-03-16 |
2011-09-21 |
BioNTech AG |
Tumor vaccination involving a humoral immune response against self-proteins
|
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
|
EP2576620A1
(en)
*
|
2010-05-26 |
2013-04-10 |
Regents Of The University Of Minnesota |
Single -chain variable fragment anti-cd133 antibodies and uses thereof
|
|
EP2576824A2
(en)
|
2010-06-07 |
2013-04-10 |
Roche Diagnostics GmbH |
Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
US20130157891A1
(en)
|
2010-06-24 |
2013-06-20 |
Xiao-Jun Li |
Organ specific diagnostic panels and methods for identification of organ specific panel proteins
|
|
WO2012070014A2
(en)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
|
|
CN103119180A
(zh)
|
2011-01-12 |
2013-05-22 |
森永乳业株式会社 |
产生具有免疫调节作用的乳的食物的筛选方法
|
|
DE102011005235B4
(de)
|
2011-03-08 |
2017-05-24 |
Sirs-Lab Gmbh |
Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
|
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2013174403A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014025199A2
(ko)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
스테필로코칼 엔테로톡신 유래의 초항원 변이체 및 이에 표적 특이적 폴리펩타이드가 연결된 융합단백질 및 그 용도
|
|
WO2014025198A2
(ko)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Lfa3 변이체 및 상기 변이체 또는 lfa3 cd2 결합영역과 이에 표적 특이적 폴리펩타이드가 연결된 융합단백질 및 그 용도
|
|
WO2014031859A2
(en)
|
2012-08-24 |
2014-02-27 |
University Of Utah Research Foundation |
Compositions and methods relating to blood-based biomarkers of breast cancer
|
|
US9856532B2
(en)
|
2012-09-07 |
2018-01-02 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (PTSD)
|
|
US20140073524A1
(en)
|
2012-09-07 |
2014-03-13 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (ptsd)
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|